首页> Journal of medical virology> Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report.

Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report.

导出 OA

翻译打印收藏纠错

第一作者： Ali S,Omrani

第一单位： Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.;Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.

作者： Ali S,Omrani ^[1] ; Ahmed,Zaqout ^[1] ; Anas,Baiou ^[2] ; Joanne,Daghfal ^[3] ; Naser,Elkum ^[4] ; Rand A,Alattar ^[3] ; Dana,Bakdach ^[5] ; Hatem,Abusriwil ^[6] ; Abdalrahman M,Mostafa ^[6] ; Bassem,Alhariri ^[6] ; Naseem,Ambra ^[6] ; Mohamed,Khatib ^[7] ; Ali M,Eldeeb ^[8] ; Zeyd,Merenkov ^[9] ; Zeinab,Fawzi ^[9] ; Saloua M,Hmissi ^[9] ; Ali A,Hssain ^[5] ; Peter V,Coyle ^[10] ; Hussam,Alsoub ^[1] ; Muna A,Almaslamani ^[1] ; Abdullatif,Alkhal ^[1]

作者单位： Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.;Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar. ^[1] Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar. ^[2] Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar. ^[3] Research Department, Sidra Medical, Doha, Qatar. ^[4] Medical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar. ^[5] Department of Internal Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar. ^[6] Critical Care and Pulmonary Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar. ^[7] Department of Clinical Imaging, Hamad Medical Corporation, Doha, Qatar. ^[8] Transfusion Medicine, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar. ^[9] Division of Virology, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar. ^[10]

关键词 COVID-19 SARS-CoV-2 convalescent plasma coronavirus passive immunotherapy